ERBB2 and breast neoplasm: Overall, these findings suggested that combined aspirin and Compound C treatment inhibited HER-2-positive breast tumor growth, possibly through the inhibition of key lipogenesis-related enzymes in HER-2-positive breast tumors (Figure 7).